Cervical cancer prevention in Australia: Planning for the future
about
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceCervical cancer screening in Australia: Past and present.Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia.Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol.
P2860
Cervical cancer prevention in Australia: Planning for the future
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cervical cancer prevention in Australia: Planning for the future
@ast
Cervical cancer prevention in Australia: Planning for the future
@en
Cervical cancer prevention in Australia: Planning for the future
@nl
type
label
Cervical cancer prevention in Australia: Planning for the future
@ast
Cervical cancer prevention in Australia: Planning for the future
@en
Cervical cancer prevention in Australia: Planning for the future
@nl
prefLabel
Cervical cancer prevention in Australia: Planning for the future
@ast
Cervical cancer prevention in Australia: Planning for the future
@en
Cervical cancer prevention in Australia: Planning for the future
@nl
P2860
P3181
P356
P1433
P1476
Cervical cancer prevention in Australia: Planning for the future
@en
P2093
A Marion Saville
P2860
P304
P3181
P356
10.1002/CNCY.21643
P407
P577
2016-04-01T00:00:00Z